The Emergence of Pharmacy Fraud
in Co-Pay Programs

Joann Whitcher, A MM&M Digital Publication
Featuring Tim Ogren, Senior Vice President, Products

Abstract

Fraud involving pharmaceutical manufacturers’ patient co-pay and voucher programs is on the rise. The increase in the number of co-pay and voucher programs, combined with the increasingly generous benefits provided by pharmaceutical manufacturers, has created a veritable breeding ground for fraudulent pharmacy activity. TrialCard and its team of experts has developed an enhanced monitoring service to protect its clients and their valuable reimbursement budgets.

Mark Droke
Chief Sales Officer
mark.droke@trialcard.com
919-415-3341